These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32510928)

  • 1.
    Rouillard KR; Markovetz MR; Bacudio LG; Hill DB; Schoenfisch MH
    ACS Infect Dis; 2020 Jul; 6(7):1940-1950. PubMed ID: 32510928
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Mucin and DNA Concentrations in Airway Mucus on Pseudomonas aeruginosa Biofilm Recalcitrance.
    Rouillard KR; Kissner WJ; Markovetz MR; Hill DB
    mSphere; 2022 Aug; 7(4):e0029122. PubMed ID: 35968965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides.
    Reighard KP; Hill DB; Dixon GA; Worley BV; Schoenfisch MH
    Biofouling; 2015; 31(9-10):775-87. PubMed ID: 26610146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP; Cathie K; Hall-Stoodley L; Cornelius V; Duignan C; Allan RN; Fernandez BO; Barraud N; Bruce KD; Jefferies J; Kelso M; Kjelleberg S; Rice SA; Rogers GB; Pink S; Smith C; Sukhtankar PS; Salib R; Legg J; Carroll M; Daniels T; Feelisch M; Stoodley P; Clarke SC; Connett G; Faust SN; Webb JS
    Mol Ther; 2017 Sep; 25(9):2104-2116. PubMed ID: 28750737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models.
    Rouillard KR; Hill DB; Schoenfisch MH
    J Cyst Fibros; 2020 Nov; 19(6):1004-1010. PubMed ID: 32205069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown
    Rozenbaum RT; van der Mei HC; Woudstra W; de Jong ED; Busscher HJ; Sharma PK
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745390
    [No Abstract]   [Full Text] [Related]  

  • 7. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis.
    Morris AJ; Jackson L; Cw Yau Y; Reichhardt C; Beaudoin T; Uwumarenogie S; Guttman KM; Lynne Howell P; Parsek MR; Hoffman LR; Nguyen D; DiGiandomenico A; Guttman DS; Wozniak DJ; Waters VJ
    NPJ Biofilms Microbiomes; 2021 Aug; 7(1):63. PubMed ID: 34349133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.
    Müller L; Murgia X; Siebenbürger L; Börger C; Schwarzkopf K; Sewald K; Häussler S; Braun A; Lehr CM; Hittinger M; Wronski S
    J Antimicrob Chemother; 2018 Oct; 73(10):2762-2769. PubMed ID: 29982453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm Dispersal, Reduced Viscoelasticity, and Antibiotic Sensitization via Nitric Oxide-Releasing Biopolymers.
    Grayton QE; Nguyen HK; Broberg CA; Ocampo J; Nagy SG; Schoenfisch MH
    ACS Infect Dis; 2023 Sep; 9(9):1730-1741. PubMed ID: 37566512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms.
    Rouillard KR; Esther CP; Kissner WJ; Plott LM; Bowman DW; Markovetz MR; Hill DB
    PLoS One; 2024; 19(2):e0294120. PubMed ID: 38394229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms.
    Thorn CR; Carvalho-Wodarz CS; Horstmann JC; Lehr CM; Prestidge CA; Thomas N
    Small; 2021 Jun; 17(24):e2100531. PubMed ID: 33978317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa.
    Soren O; Rineh A; Silva DG; Cai Y; Howlin RP; Allan RN; Feelisch M; Davies JC; Connett GJ; Faust SN; Kelso MJ; Webb JS
    J Antimicrob Chemother; 2020 Jan; 75(1):117-125. PubMed ID: 31682251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of particle size of inhaled tobramycin dry powder on the eradication of Pseudomonas aeruginosa biofilms.
    Aljalamdeh R; Price R; Jones MD; Bolhuis A
    Eur J Pharm Sci; 2021 Mar; 158():105680. PubMed ID: 33346008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms.
    Frisch S; Boese A; Huck B; Horstmann JC; Ho DK; Schwarzkopf K; Murgia X; Loretz B; de Souza Carvalho-Wodarz C; Lehr CM
    J Antimicrob Chemother; 2021 May; 76(6):1472-1479. PubMed ID: 33712824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.